Annual Cash & Cash Equivalents
$6.92 M
-$17.81 M-72.01%
December 31, 2022
Summary
- As of February 26, 2025, BLPH annual cash & cash equivalents is $6.92 million, with the most recent change of -$17.81 million (-72.01%) on December 31, 2022.
- During the last 3 years, BLPH annual cash & cash equivalents has fallen by -$2.95 million (-29.88%).
Performance
BLPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.38 M
-$6.19 M-58.56%
September 30, 2023
Summary
- As of February 26, 2025, BLPH quarterly cash and cash equivalents is $4.38 million, with the most recent change of -$6.19 million (-58.56%) on September 30, 2023.
- Over the past year, BLPH quarterly cash and cash equivalents has dropped by -$6.93 million (-61.28%).
Performance
BLPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.0% | -61.3% |
| 3 y3 years | -29.9% | -61.3% |
| 5 y5 years | -76.0% | -77.6% |
BLPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.0% | at low | -82.3% | at low |
| 5 y | 5-year | -85.4% | at low | -92.6% | at low |
| alltime | all time | -85.4% | -100.0% | -93.0% | -100.0% |
Bellerophon Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $4.38 M(-58.6%) |
| Jun 2023 | - | $10.57 M(-30.3%) |
| Mar 2023 | - | $15.17 M(+119.1%) |
| Dec 2022 | $6.92 M(-72.0%) | $6.92 M(-38.8%) |
| Sep 2022 | - | $11.32 M(-30.7%) |
| Jun 2022 | - | $16.33 M(-18.4%) |
| Mar 2022 | - | $20.00 M(-19.1%) |
| Dec 2021 | $24.74 M(-48.0%) | $24.74 M(-13.9%) |
| Sep 2021 | - | $28.71 M(-16.3%) |
| Jun 2021 | - | $34.30 M(-13.5%) |
| Mar 2021 | - | $39.67 M(-16.6%) |
| Dec 2020 | $47.56 M(+381.6%) | $47.56 M(-11.9%) |
| Sep 2020 | - | $53.97 M(-9.0%) |
| Jun 2020 | - | $59.31 M(+590.0%) |
| Mar 2020 | - | $8.60 M(-13.0%) |
| Dec 2019 | $9.87 M(-40.7%) | $9.87 M(-23.1%) |
| Sep 2019 | - | $12.84 M(-23.6%) |
| Jun 2019 | - | $16.80 M(-18.8%) |
| Mar 2019 | - | $20.68 M(+24.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $16.64 M(-42.3%) | $16.64 M(-14.9%) |
| Sep 2018 | - | $19.55 M(-16.5%) |
| Jun 2018 | - | $23.40 M(-17.4%) |
| Mar 2018 | - | $28.35 M(-1.6%) |
| Dec 2017 | $28.82 M(+103.0%) | $28.82 M(-10.7%) |
| Sep 2017 | - | $32.28 M(+194.3%) |
| Jun 2017 | - | $10.97 M(-19.0%) |
| Mar 2017 | - | $13.54 M(-4.7%) |
| Dec 2016 | $14.20 M(+126.9%) | $14.20 M(+261.4%) |
| Sep 2016 | - | $3.93 M(+201.4%) |
| Jun 2016 | - | $1.30 M(+2.7%) |
| Mar 2016 | - | $1.27 M(-79.7%) |
| Dec 2015 | $6.26 M(-62.8%) | $6.26 M(-73.8%) |
| Sep 2015 | - | $23.91 M(-50.7%) |
| Jun 2015 | - | $48.51 M(-22.9%) |
| Mar 2015 | - | $62.94 M(+274.3%) |
| Dec 2014 | $16.82 M(>+9900.0%) | $16.82 M(-45.1%) |
| Sep 2014 | - | $30.61 M(>+9900.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00 | - |
FAQ
- What is Bellerophon Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual cash & cash equivalents year-on-year change?
- What is Bellerophon Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Bellerophon Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BLPH is $6.92 M
What is the all time high annual cash & cash equivalents for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual cash & cash equivalents is $47.56 M
What is Bellerophon Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BLPH annual cash & cash equivalents has changed by -$17.81 M (-72.01%)
What is Bellerophon Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLPH is $4.38 M
What is the all time high quarterly cash and cash equivalents for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly cash and cash equivalents is $62.94 M
What is Bellerophon Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BLPH quarterly cash and cash equivalents has changed by -$6.93 M (-61.28%)